Clinical Trial Update: Foundation and Clinical About the Expression of PD-1 in Peripheral Blood T Lymphocytes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update examining PD-1 expression in peripheral blood T cells for non-small cell lung cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Xin-Hua Xu | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED